← SynDRA
CHS-828
SynDRA canonical compound SYN0000995 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | NAMPT |
| Mechanism of action | NAMPT inhibitor |
| Indication | lung cancer |
| Disease area | Oncology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- CHS 828
- CHS828
- GMX-1778
- GMX1778
- Cancer therapeutics, LEO Pharma
- GMX 1778
- 8LAP87DNSZ
- RefChem:577082
- Pyridyl Cyanoguanidine CHS 828
- 2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine
- 1-[6-(4-Chlorophenoxy)hexyl]-3-cyano-2-pyridin-4-ylguanidine
- MFCD03700766
- UNII-8LAP87DNSZ
- C19H22ClN5O
- GMX1778 (CHS828)
- GMX1778(CHS-828)
- SCHEMBL504150
- SCHEMBL504151
- SCHEMBL504892
- SCHEMBL810184
- SCHEMBL810990
- orb1306792
- SCHEMBL2672576
- SCHEMBL12083293
- SCHEMBL16312347
- SCHEMBL23924547
- BDBM81396
- CHEBI:95016
- EX-A713
- BOIPLTNGIAPDBY-UHFFFAOYSA-N
- GLXC-04065
- GMX1778? CHS-828
- BDBM50435350
- HB3837
- s8117
- AKOS026750302
- AKOS028109359
- AKOS032960393
Look up CHS-828 in the interactive SynDRA portal →